B
arrett's oesophagus consists of a metaplastic transformation of the lining of the distal oesophagus in which the normal squamous epithelium is replaced by a specialised columnar epithelium with goblet cells. 1 Barrett's oesophagus is thought to be the precursor lesion to adenocarcinoma of the oesophagus, which has become the most rapidly increasing cancer among white men in Western countries. [2] [3] [4] A search for a possible association between Barrett's oesophagus and Helicobacter pylori infection was logical because H pylori infection causes gastro-duodenal mucosal inflammation, leading to metaplastic transformation of the gastric epithelium and to gastric cancer. 5 6 However, when H pylori is present in the oesophagus, it is typically found associated with gastric-type epithelium, and not on specialised metaplastic Barrett's epithelium, and the consensus is that a direct role for H pylori in adenocarcinoma is very unlikely. [7] [8] [9] [10] [11] [12] ''Helicobacter pylori infection in a patient with an abnormal reflux barrier would depend in part on the pattern and severity of gastritis'' Barrett's oesophagus is a complication of gastro-oesophageal reflux disease (GERD). The presence of gastro-oesophageal reflux causing clinical manifestations (disease) is related to the duration and causticity of the refluxate (the oesophageal acid load). 13 Helicobacter pylori infection directly affects the stomach's ability to produce acid, 13 14 and the recognition that the prevalence of H pylori infection was decreasing in the same population in which oesophageal adenocarcinoma was increasing (white men) suggested that this inverse association may reflect loss of H pylori induced damage to the stomach. 15 The presence of H pylori infection also results in dysregulation of the normal acid inhibitory reflexes associated with low antral pH, leading to prolonged acid secretion after a meal, such that antral predominant H pylori gastritis is associated with increased acid production. 16 In contrast, H pylori induced inflammation in the acid secreting gastric corpus impairs the ability of parietal cells to produce acid, and eventually may result in loss of glandular elements and a permanent reduction in acidity. Therefore, H pylori infection in corpus gastritis has been likened to a biological antisecretory agent. 14 Theoretically, the effect of H pylori infection in a patient with an abnormal reflux barrier would depend in part on the pattern and severity of gastritis. 13 One would expect that patients without H pylori infection and/or patients with antral predominant gastritis and normal or increased acid secretion would have the highest risk for GERD and Barrett's oesophagus. The risk would decrease progressively with increasing corpus gastritis, and would essentially be absent in patients with atrophic corpus gastritis. 13 Helicobacter pylori also vary with respect to their ability to cause mucosal inflammation. Helicobacter pylori that contain the cag pathogenicity island (CagA positive) cause more inflammation than those lacking the island, so that with all other things being equal, infection with CagA positive H pylori should be associated with the lowest incidence of clinical GERD and of Barrett's oesophagus. 13 14 The clinical observations are consistent with this reasoning. [17] [18] [19] [20] Both GERD and adenocarcinoma of the oesophagus are rare in countries where atrophic gastritis is common, and this has been attributed to the fact that H pylori associated inflammation and/or destruction of the gastric corpus reduces the oesophageal acid load to below the threshold that will allow the development of either symptomatic GERD or Barrett's oesophagus. 13 Nonetheless, Barrett's oesophagus can be found in regions where both CagA positive H pylori infections and gastric cancer are common. Colombia is one such country. [21] [22] [23] [24] This study was designed to test whether the inverse association between H pylori, especially CagA positive H pylori, and Barrett's oesophagus is also present in Colombia. We hypothesised that patients with Barrett's oesophagus in Colombia would be primarily H pylori negative, and because most Colombians with H pylori infection are CagA positive, those with H pylori infection would be infected with a CagA positive strain. To test these hypotheses, we evaluated the relation between Barrett's oesophagus and CagA positive H pylori in Colombia.
METHODS

Patients
Our study population consisted of consecutive patients with long segment Barrett's oesophagus (at least 3 cm above the gastro-oesophageal junction) examined at the gastroenterology outpatient unit of the department of internal medicine of the National University, Bogotá, Colombia. Patients were excluded if they had had H pylori eradication treatment, gastric or gallbladder surgery, or if they did not give written consent to participate in our study. Patients were not excluded if they were receiving antisecretory drugs. The protocol was approved by the ethical committee of the department of internal medicine, National University of Colombia.
Biopsy specimens
Mucosal biopsy specimens were obtained from the four quadrants of the oesophagus and additional biopsies were obtained from the gastric corpus and antrum. Each specimen was placed in a formalin bottle and routinely processed. For a control group, gastric biopsies were obtained from Colombian patients diagnosed with simple gastritis (for example, no coexisting ulcer disease, oesophagitis, or gastric cancer). Glass slides and/or paraffin wax embedded tissue blocks were shipped to the gastrointestinal mucosal pathology laboratory at Baylor College of Medicine in Houston, Texas, USA.
Serial sections were stained with a triple stain. [25] [26] [27] Each specimen was reviewed by an experienced gastrointestinal pathologist (HEZ) and a trainee (MK) and scored using a visual analogue scale from 0 (absent/normal) to 5 (maximal intensity) for H pylori, active and chronic inflammation, and intestinal metaplasia and atrophy. 28 CagA antisera Two to three month old specific pathogen free New Zealand white rabbits of either sex (Charles River Laboratories, Wilmington, Massachusetts, USA) received three intramuscular injections of a mixture of equal volumes of 50 mg of purified recombinant CagA (Chiron-RIBA, Chiron Corp, Emeryville, California, USA) H pylori protein and Freund's adjuvant in a final volume of 5 ml. Freund's complete adjuvant was used for the first immunisation and Freund's incomplete adjuvant was used subsequently.
Immunohistochemistry studies
For immunophenotyping of CagA antisera status, 4 mm thick sections of formalin fixed, paraffin wax embedded tissue were stained using a modified streptavidin-biotin complex method with antigen retrieval. Briefly, slides were pretreated for antigen retrieval with proteinase K for two minutes, then steamed for 20 minutes in a Black and Decker steamer in 10 mmol/litre citrate buffer (pH 6.0), followed by cooling for 30 minutes. The following reagents were then added sequentially (at room temperature unless stated otherwise):
inhibitor of endogenous peroxidase; biotin blocking system (Dako, Carpinteria, California, USA); primary antibody, diluted 1/50, overnight at 37˚C; biotinylated goat antirabbit secondary antibody, diluted 1/1000 in 5% skimmed milk in phosphate buffered saline, for one hour; avidin-horseradish peroxidase complex for 30 minutes; and 3,39-diaminobenzidine tetrahydrochloride for five minutes. Slides were counterstained with Alcian blue. Sensitivity and specificity were tested using gastric biopsies from patients in whom the CagA status was unequivocally known based on polymerase chain reaction on culture grown colonies.
Statistical methods
Analyses used SigmaStat 3.0 (SPSS, Chicago, Illinois, USA). Fisher's exact test or, when appropriate, the x 2 test (both two tailed), were used for comparison of proportions. Significance of differences and associations was determined by p values of less than 0.05.
RESULTS
Gastric and oesophageal mucosal biopsies were obtained from 51 patients (39 men: mean age, 57.8 years; SD, 13; 12 women: mean age, 51.8 years; SD, 14) with long segment Barrett's oesophagus. One patient had high grade dysplasia, and two had low grade dysplasia in Barrett's epithelium. In addition to Barrett's oesophagus, four other patients had duodenal ulcers. The control group consisted of 24 Colombian patients with H pylori gastritis.
CagA immunostaining
Gastric mucosal biopsy specimens from 36 patients with active H pylori infection in whom the infecting H pylori had previously been typed in relation to CagA status using the polymerase chain reaction (24 Colombian patients, with 19 being CagA positive and five CagA negative; 12 US patients, comprising six with CagA positive and six with CagA negative infections) were tested. In US cases there were no false positives or false negatives (sensitivity and specificity, 100%). In the Colombian cases, there were two false positives (sensitivity and specificity were 100% and 60%, respectively), possibly related to mixed infections. 29 Overall, the immunostaining had a sensitivity of 100% and a specificity of 81.8%, such that the proportion with CagA positive infections might be overestimated.
Helicobacter pylori and CagA status among patients with Barrett's oesophagus Glass slides were obtained from 51 patients with Barrett's oesophagus. Paraffin wax embedded tissue blocks were available from 38 patients; only one block was received for 15 patients. Examination of the gastric mucosal biopsy specimens from the 51 patients with long segment Barrett's showed that 32 had active H pylori infection. CagA status was evaluated in a subset of 23 patients for whom a tissue block was available from both the antrum and corpus, and in whom the triple stain confirmed the presence of active H pylori infection; eight were infected with CagA positive H pylori. In the control H pylori infected patients, 19 of 24 were infected with CagA positive H pylori (p = 0.005).
Gastric mucosal intestinal metaplasia among patients with Barrett's oesophagus
We compared the prevalence of intestinal metaplasia among a subset of patients who had adequate gastric specimens available from both the antrum and the corpus (15 patients with Barrett's oesophagus and 24 H pylori infected controls). None of the patients with Barrett's oesophagus had gastric intestinal metaplasia compared with 11 of the 24 patients with H pylori gastritis (p = 0.015). Nine cases from the control group with intestinal metaplasia were infected with CagA positive H pylori. The site of intestinal metaplasia in the CagA positive patients was the antrum alone in five and the antrum and the corpus in four. Both CagA negative cases had antral intestinal metaplasia.
DISCUSSION
Colombia is typical of a developing country in that H pylori infection is present in most adults, with most individuals being infected with a CagA positive strain. [21] [22] [23] Gastric cancer is common in Colombia, 30 31 but the association between H pylori (or a particular strain) and GERD/Barrett's oesophagus has not been adequately studied.
Our study examined the relation between H pylori and long segment Barrett's oesophagus in Colombia. As we anticipated, H pylori infection was present in most Colombians with long segment Barrett's oesophagus (32 of 51; 62.7%), which is higher than the prevalence of H pylori among patients with Barrett's oesophagus in the USA (10-32.9%). 10 32-34 Our second hypothesis was that most H pylori infected patients with Barrett's oesophagus would have CagA positive H pylori infections, but this was disproved because CagA positive H pylori was present in only approximately one third of those with active H pylori infections. This frequency is higher than the prevalence reported among patients with Barrett's oesophagus in the USA (0-15.0%), [17] [18] [19] [20] and much lower than the prevalence reported among the general population of H pylori infected Colombians. 22 35 Our data are reminiscent of a study in Italy where CagA positive H pylori infections were present in 42% of patients with Barrett's oesophagus compared with 80% of control infected patients (p , 0.03). 36 In addition, the gastric mucosa of Italian patients with Barrett's oesophagus was typically non-atrophic: intestinal metaplasia was seen in 13% of the patients with Barrett's oesophagus compared with 30% of controls (p , 0.03). 36 ''None of the patients with Barrett's oesophagus had intestinal metaplasia in gastric mucosal biopsies, whereas intestinal metaplasia was found in 11 of 24 controls with H pylori gastritis''
In Colombia, as elsewhere, Barrett's oesophagus is primarily a disease of older men. 37 38 Interestingly, none of the Colombian women with long segment Barrett's oesophagus had CagA positive H pylori infections. In addition, none of the patients with Barrett's oesophagus had intestinal metaplasia in gastric mucosal biopsies, whereas intestinal metaplasia was found in 11 of 24 controls with H pylori gastritis. These data are consistent with the hypothesis that Barrett's oesophagus is related to the degree and severity of gastro-oesophageal reflux, reflected in the oesophageal acid load. 13 Reduced acid secretion is associated with corpus gastritis, such that infection with CagA positive H pylori would be expected to cause a more intense reduction than infection with CagA negative infections. 13 14 Colombians with long segment Barrett's oesophagus are somewhat unusual because they were more likely to be infected with CagA negative H pylori and not to have intestinal metaplasia in the stomach.
Our study focused on the relation between the presence of H pylori infection, particularly the cag pathogenicity island, and Barrett's oesophagus. There are several other host and H pylori related factors that may also be important in reducing or enhancing the odds of developing a particular outcome other than the presence of the cag pathogenicity island. For example, genetic polymorphisms in proflammatory cytokine genes can result in an enhanced inflammatory response to any stimulus (such as periodontal disease), independent of whether H pylori infection is present, 39 and have been shown to be important in gastric 40 and oesophageal carcinoma. 41 Alterations in host factors, such as Lewis antigens, may also be important in relation to H pylori infection 42 ; however, polymorphisms in HLA antigens have not been shown to be important. 43 Understanding the interactions between host, H pylori, and environmental factors is difficult, because synergistic effects between environmental, host (for example, genetic polymorphisms), and H pylori virulence factors need to be taken into account. 39 44 45 Authors are only allowed one affiliation each.
